These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19720497)

  • 1. Risk factors for tardive dyskinesia in adults with intellectual disability, comorbid psychopathology, and long-term psychotropic use.
    Matson JL; Fodstad JC; Neal D; Dempsey T; Rivet TT
    Res Dev Disabil; 2010; 31(1):108-16. PubMed ID: 19720497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tardive dyskinesia and intellectual disability: an examination of demographics and topography in adults with dual diagnosis and atypical antipsychotic use.
    Fodstad JC; Bamburg JW; Matson JL; Mahan S; Hess JA; Neal D; Holloway J
    Res Dev Disabil; 2010; 31(3):750-9. PubMed ID: 20207106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tardive dyskinesia associated with metoclopramide in persons with developmental disabilities.
    Matson JL; Mayville EA; Bielecki J; Smalls Y; Eckholdt CS
    Res Dev Disabil; 2002; 23(3):224-33. PubMed ID: 12102590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyskinesia in mentally handicapped women: relationship to level of handicap, age and neuroleptic exposure.
    Farren CK; Dinan TG
    Acta Psychiatr Scand; 1994 Sep; 90(3):210-3. PubMed ID: 7810345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tardive dyskinesia in the mentally retarded: comparison of prevalence, risk factors and topography with a schizophrenic population.
    Cohen S; Khan A; Zheng Y; Chiles J
    Acta Psychiatr Scand; 1991 Mar; 83(3):234-7. PubMed ID: 1674398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tardive dyskinesia in young mentally retarded individuals.
    Gualtieri CT; Schroeder SR; Hicks RE; Quade D
    Arch Gen Psychiatry; 1986 Apr; 43(4):335-40. PubMed ID: 2869741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents.
    Gualtieri CT; Quade D; Hicks RE; Mayo JP; Schroeder SR
    Am J Psychiatry; 1984 Jan; 141(1):20-3. PubMed ID: 6140865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis of tardive dyskinesia: implications for assessment and treatment.
    Valdovinos MG; Roberts C; Kennedy CH
    J Appl Behav Anal; 2005; 38(2):239-42. PubMed ID: 16033170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postural stability, tardive dyskinesia and developmental disability.
    Ko YG; Van Emmerik RE; Sprague RL; Newell KM
    J Intellect Disabil Res; 1992 Aug; 36 ( Pt 4)():309-23. PubMed ID: 1356038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New findings on tardive dyskinesia in a community sample.
    O'Hara P; Brugha TS; Lesage A; Wing J
    Psychol Med; 1993 May; 23(2):453-65. PubMed ID: 8101384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tardive dyskinesia: a review.
    Latimer PR
    Can J Psychiatry; 1995 Sep; 40(7 Suppl 2):S49-54. PubMed ID: 8564917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tardive dyskinesia in 2 patients treated with ziprasidone.
    Ananth J; Burgoyne KS; Niz D; Smith M
    J Psychiatry Neurosci; 2004 Nov; 29(6):467-9. PubMed ID: 15644988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study.
    Morgenstern H; Glazer WM
    Arch Gen Psychiatry; 1993 Sep; 50(9):723-33. PubMed ID: 8102845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of the Matson Evaluation of Drug Side Effects (MEDS).
    Matson JL; Cervantes PE
    Res Dev Disabil; 2013 May; 34(5):1849-53. PubMed ID: 23528442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Psychopharmacological therapy in mental retardation--comparison of the years 1991 and 2005].
    Engel C; Szrama E; Hässler F
    Psychiatr Prax; 2010 Nov; 37(8):391-6. PubMed ID: 20703984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of severe and mild tardive dyskinesia: implications for etiology.
    Gardos G; Cole JO; Schniebolk S; Salomon M
    J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief report: risperidone for severely disturbed behavior and tardive dyskinesia in developmentally disabled adults.
    Khan BU
    J Autism Dev Disord; 1997 Aug; 27(4):479-89. PubMed ID: 9261670
    [No Abstract]   [Full Text] [Related]  

  • 18. Involuntary orofacial movements in hospitalised patients with mental handicap or epilepsy: relationship to developmental/intellectual deficit and presence or absence of long-term exposure to neuroleptics.
    Youssef HA; Waddington JL
    J Neurol Neurosurg Psychiatry; 1988 Jun; 51(6):863-5. PubMed ID: 2900294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tardive dyskinesia in the aged. Duration of treatment relationships.
    Toenniessen LM; Casey DE; McFarland BH
    Arch Gen Psychiatry; 1985 Mar; 42(3):278-84. PubMed ID: 2858189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment predictors of extrapyramidal side effects in patients with tardive dyskinesia: results from Veterans Affairs Cooperative Study 394.
    Lohr JB; Caligiuri MP; Edson R; Lavori P; Adler LA; Rotrosen J; Hitzemann R
    J Clin Psychopharmacol; 2002 Apr; 22(2):196-200. PubMed ID: 11910266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.